SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2536<i>>I got interested because this looked like yesterdays and earlier moDewDiligence_on_SI-1/14/2010
2535Thanks for posting. I got interested because this looked like yesterdays and earRockyBalboa-1/14/2010
2534Today was a perfect time to sell insofar as ETRM's product doesn't work DewDiligence_on_SI-1/14/2010
2533ETRM crashes on stock offering 56~64c BRIEF-EnteroMedics announces $4.8 millionRockyBalboa-1/14/2010
2532ROSG, MRNA: Love those "direct stock offerings". Very similar - MRNA dRockyBalboa-1/14/2010
25315:29PM Rosetta Genomics down 34% at $2.05 following 17:22 news (ROSG) : 5:22PIan@SI-1/13/2010
2530AFFX is down nearly 15% on a Barclays Capital downgrade.idos-1/13/2010
2529Cyclacel (CYCC), finances after an amazing run on in vitro data. Off 18%. Cheetuck-1/11/2010
2528SNTA -17% to $4.5 on this news: LEXINGTON, Mass. (AP) -- Synta Pharmaceuticals Itnsaf-1/8/2010
2527Contract possibility made it a high flier today! Up from 1.44 to 3.44 and tradmlkr-12/30/2009
2526Trimeris off 15% or so as Arigene officially ends its tender offer due to inabiltuck-12/29/2009
2525PSDV -16% Confusion over the FAME trial results The test was (excluding safetyJohn McCarthy-12/24/2009
2524SNTA -16% at its low, closed -12%, giving up gains of past two daystnsaf-12/23/2009
2523<i>>Teva is a giant in the generic drug business but has no standing whDewDiligence_on_SI-12/21/2009
2522Adam Feuerstein's comments on the OGXI-TEVA deal BOTHELL, Wash. (TheStreet)tnsaf-12/21/2009
2521Not that I'm aware of.nigel bates-12/21/2009
2520Too bad! What a need! Is ARK trading in the USA?mlkr-12/21/2009
2519Smallcap OGXI severely off (-$8.25, or 27%) after inking a deal with teva: BRIERockyBalboa-12/21/2009
2518up again to 19 cents from 3 cents with an unusual twist; icelandic style!mlkr-12/18/2009
2517VIOPD ch. 11.. 65 m debt vs 18 m assets,..CYCC and SNSS in this space getting mmlkr-12/18/2009
2516I never knew you had a sense of humor! creative one tho! LOL.mlkr212/18/2009
2515LONDON, Dec 18 (Reuters) - European regulators on Friday recommended against appnigel bates-12/18/2009
2514<i>>Didnt HEB and CVM found each other without approval from their sharDewDiligence_on_SI-12/16/2009
2513Didnt HEB and CVM found each other without an approval from their shareholders? mlkr-12/16/2009
251223 dollars lost PS; 14 dollars stox now.. yet volume is 1200 shares.. Pink stox.mlkr-12/16/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News